These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2603805)
21. Symptomatic and pathophysiological observations in a modified animal model of allergic rhinitis. Zhao Y; Woo JK; Leung PC; Chen GG; Wong YO; Liu SX; van Hasselt CA Rhinology; 2005 Mar; 43(1):47-54. PubMed ID: 15844502 [TBL] [Abstract][Full Text] [Related]
22. Plasma extravasation through neuronal stimulation in human nasal mucosa in the setting of allergic rhinitis. Sanico AM; Atsuta S; Proud D; Togias A J Appl Physiol (1985); 1998 Feb; 84(2):537-43. PubMed ID: 9475863 [TBL] [Abstract][Full Text] [Related]
23. Platelet-activating factor (PAF)-induced rhinitis and involvement of PAF in allergic rhinitis in guinea pigs. Misawa M; Iwamura S Jpn J Pharmacol; 1990 Oct; 54(2):217-26. PubMed ID: 2077186 [TBL] [Abstract][Full Text] [Related]
24. [A study of chemical mediator release in experimental nasal allergy of guinea pigs]. Shirasaki H; Kojima T; Asakura K; Kataura A Nihon Jibiinkoka Gakkai Kaiho; 1988 Jul; 91(7):1049-53. PubMed ID: 2460601 [No Abstract] [Full Text] [Related]
25. Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway. Turner PJ; Dear JW; Foreman JC Br J Pharmacol; 2000 Feb; 129(3):525-32. PubMed ID: 10711351 [TBL] [Abstract][Full Text] [Related]
26. [Kinins and kallikrein in nasal secretion after antigen challenge in patients with allergic rhinitis]. Nishiyama K Nihon Jibiinkoka Gakkai Kaiho; 1994 Aug; 97(8):1512-22. PubMed ID: 7931807 [TBL] [Abstract][Full Text] [Related]
27. The effects of a kinin antagonist on changes in lung function and plasma extravasation into the airways following challenge of sensitized guinea-pigs. Featherstone RL; Parry JE; Church MK Clin Exp Allergy; 1996 Feb; 26(2):235-40. PubMed ID: 8835133 [TBL] [Abstract][Full Text] [Related]
28. A new rhinitis model using chemical mediators in rats. Misawa M Jpn J Pharmacol; 1988 Sep; 48(1):15-22. PubMed ID: 3199605 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis. Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271 [TBL] [Abstract][Full Text] [Related]
30. Effects of flutropium on experimental models of drug- and allergy-induced rhinitis in guinea pigs. Mizuno H; Kawamura Y; Iwase N; Ohno H Jpn J Pharmacol; 1991 Mar; 55(3):321-8. PubMed ID: 1677436 [TBL] [Abstract][Full Text] [Related]
31. [Nasal response to chemical mediators in nasal allergy]. Mezawa A Nihon Jibiinkoka Gakkai Kaiho; 1988 Sep; 91(9):1444-50. PubMed ID: 3199260 [No Abstract] [Full Text] [Related]
32. Contralateral differences among biomarkers determined by a modified nasal lavage technique after unilateral antigen challenge. Wihl JA; Baumgarten CR; Petersson G Allergy; 1995 Apr; 50(4):308-15. PubMed ID: 7573813 [TBL] [Abstract][Full Text] [Related]
33. Nitric oxide is a mediator of the late-phase response in an animal model of nasal allergy. Durland WF; Lane AP; Durland KW; Smith TL; Johnson KL; Prazma J; Pillsbury HC Otolaryngol Head Neck Surg; 2000 May; 122(5):706-11. PubMed ID: 10793351 [TBL] [Abstract][Full Text] [Related]
34. Increased secretion of glandular-kallikrein in the bronchial washings induced by intravenous injection of leukotriene C4 in guinea-pigs. Jin HY; Katori M; Majima M; Sunahara N Br J Pharmacol; 1992 Mar; 105(3):632-8. PubMed ID: 1628150 [TBL] [Abstract][Full Text] [Related]
35. [The effect of desloratadine on the TXB2 and leukotrienes levels in the nasal lavage fluid of allergic rhinitis animal model]. Zhao Y; Van Hasselt CA; Woo K; Wong Y; Leung P Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(8):365-7. PubMed ID: 16075993 [TBL] [Abstract][Full Text] [Related]
36. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls. de Graaf-in t Veld C; Garrelds IM; Koenders S; Gerth van Wijk R Clin Exp Allergy; 1996 Aug; 26(8):903-8. PubMed ID: 8877155 [TBL] [Abstract][Full Text] [Related]
37. [Mediators of immunologic inflammation of the respiratory tract]. Miadonna A; Tedeschi A Boll Ist Sieroter Milan; 1988; 67(5-6):369-76. PubMed ID: 3155333 [TBL] [Abstract][Full Text] [Related]
38. Involvement of thromboxane A2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis. Yamasaki M; Mizutani N; Sasaki K; Nabe T; Matsumoto T; Ashida Y; Kohno S Inflamm Res; 2001 Sep; 50(9):466-73. PubMed ID: 11603852 [TBL] [Abstract][Full Text] [Related]
39. Effect of vascular endothelial growth factor on nasal vascular permeability. Matsune S; Ohori J; Yoshifuku K; Kurono Y Laryngoscope; 2010 Apr; 120(4):844-8. PubMed ID: 20213656 [TBL] [Abstract][Full Text] [Related]
40. Effect of histamine on the permeability of the nasal mucosa in vivo. Yang TQ; Takeuchi K; Hayashi S; Majima Y Acta Otolaryngol; 2003 Apr; 123(3):401-5. PubMed ID: 12737298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]